Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Eledon Pharmaceuticals, Inc. (ELDN) had Weighted-Average Shares Outstanding (Diluted) of 77.13M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-6.50M |
|
-- |
|
-- |
|
$17.96M |
|
$-17.96M |
|
$11.47M |
|
$-6.50M |
|
$-6.50M |
|
$-6.50M |
|
$-6.50M |
|
$-6.50M |
|
$-6.50M |
|
$-17.96M |
|
$-17.89M |
|
77.13M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
77.13M |
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$127.72M |
|
-- |
|
$33.59M |
|
$161.31M |
|
$9.19M |
|
-- |
|
$37.54M |
|
$46.73M |
|
$114.58M |
|
$114.58M |
|
$114.58M |
|
59.88M |
|
| Cash Flow Statement Financials | |
$-16.06M |
|
$3.89M |
|
$0.12M |
|
$20.55M |
|
$8.50M |
|
$-12.05M |
|
$2.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.91 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.67% |
|
-5.67% |
|
-4.03% |
|
-5.67% |
|
$1.91 |
|
$-0.21 |
|
$-0.21 |
|